Verona Pharma PLC ADR Working Capital to Net Assets Ratio
Verona Pharma PLC ADR working capital to net assets ratio. Verona Pharma PLC ADR (VRNA) has a Working Capital to Net Assets ratio of 178.8% as of June 2025. Working capital of $497.61 Million (current assets of $548.85 Million minus current liabilities of $51.24 Million) is measured against net assets of $278.27 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Verona Pharma PLC ADR (2005–2024)
Working capital to net assets ratio of Verona Pharma PLC ADR from 2005 to 2024. This chart shows how Verona Pharma PLC ADR's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2005 to 2024. As of June 2025, the ratio stands at 178.8%, reflecting working capital of $497.61 Million against net assets of $278.27 Million USD. Explore Verona Pharma PLC ADR strategic investment ratio to see how much of total assets are deployed in long-term investments.
Verona Pharma PLC ADR Working Capital to Net Assets Ratio by Year (2005–2024)
Verona Pharma PLC ADR working capital to net assets ratio by year from 2005 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Verona Pharma PLC ADR from 2005 to 2024, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see VRNA total asset value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 200.9% | $410.89 Million | $204.56 Million | $453.57 Million | $42.68 Million | ▲ +88.1 pp |
| 2023 | 112.7% | $281.02 Million | $249.28 Million | $289.71 Million | $8.69 Million | ▲ +15.5 pp |
| 2022 | 97.2% | $223.97 Million | $230.47 Million | $243.00 Million | $19.03 Million | ▲ +4.9 pp |
| 2021 | 92.3% | $136.64 Million | $148.00 Million | $170.06 Million | $33.42 Million | ▼ -9.5 pp |
| 2020 | 101.9% | $188.30 Million | $184.85 Million | $202.50 Million | $14.20 Million | ▲ +9.4 pp |
| 2019 | 92.4% | $41.05 Million | $44.40 Million | $53.66 Million | $12.61 Million | ▼ -5.2 pp |
| 2018 | 97.6% | $77.96 Million | $79.86 Million | $90.94 Million | $12.97 Million | ▼ -0.6 pp |
| 2017 | 98.2% | $106.06 Million | $107.95 Million | $117.68 Million | $11.62 Million | ▲ +2.7 pp |
| 2016 | 95.6% | $40.64 Million | $42.53 Million | $54.05 Million | $13.41 Million | ▲ +28.3 pp |
| 2015 | 67.3% | $5.57 Million | $8.28 Million | $8.26 Million | $2.69 Million | ▼ -17.9 pp |
| 2014 | 85.2% | $16.71 Million | $19.62 Million | $17.52 Million | $816.08K | ▲ +67.5 pp |
| 2013 | 17.6% | $600.41K | $3.41 Million | $1.41 Million | $806.89K | ▼ -19.6 pp |
| 2012 | 37.2% | $1.57 Million | $4.21 Million | $1.89 Million | $322.11K | ▼ -23.5 pp |
| 2011 | 60.8% | $3.82 Million | $6.29 Million | $4.06 Million | $242.21K | ▲ +6.7 pp |
| 2010 | 54.1% | $2.88 Million | $5.33 Million | $3.20 Million | $317.94K | ▼ -11.2 pp |
| 2009 | 65.2% | $4.73 Million | $7.25 Million | $5.19 Million | $464.08K | ▲ +4.2 pp |
| 2008 | 61.1% | $3.57 Million | $5.85 Million | $3.69 Million | $123.01K | ▲ +14.8 pp |
| 2007 | 46.3% | $2.65 Million | $5.73 Million | $2.96 Million | $311.35K | ▼ -14.0 pp |
| 2006 | 60.3% | $4.60 Million | $7.64 Million | $4.73 Million | $129.31K | ▼ -39.7 pp |
| 2005 | 100.0% | $1.68 Million | $1.68 Million | $1.71 Million | $20.65K | — |